Sign In
Buy ABCL
$5.72
-0.410 (-6.69%)
At Close: Jun 03, 2026
AbCellera Biologics Inc. (ABCL) Reports Next Week: Wall Street Expects Earnings Growth
11:18am, Tuesday, 01'st Nov 2022
AbCellera Biologics Inc. (ABCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AbCellera Biologics: COVID Antibody Set To Provide Continued Funding
12:42am, Sunday, 14'th Aug 2022
AbCellera Biologics reported Q2 numbers that were not all that impressive; however, the news of the commercialization agreement its partner Lilly inked has driven shares to near YTD highs. The commerc
AbCellera Reports Q2 2022 Business Results
06:17pm, Wednesday, 10'th Aug 2022
AbCellera (ABCL) recently announced its Q2 2022 business results. These are the details.
Why AbCellera Biologics Rallied as Much as 24% on Wednesday
01:20pm, Wednesday, 10'th Aug 2022
The contract drug developer's stock is finally shaking off the froth of its initial public offering.
AbCellera Biologics Inc. (ABCL) CEO Dr. Carl Hansen on Q2 2022 Results - Earnings Call Transcript
12:10am, Wednesday, 10'th Aug 2022
AbCellera Biologics Inc. (NASDAQ:ABCL ) Q2 2022 Earnings Conference Call August 9, 2022 5:00 PM ET Company Participants Tryn Stimart - Chief Legal and Compliance Officer Dr. Carl Hansen - President an
AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue Estimates
07:33pm, Tuesday, 09'th Aug 2022
AbCellera Biologics Inc. (ABCL) delivered earnings and revenue surprises of -150% and 40%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
AbCellera to Report Second Quarter 2022 Financial Results on August 9, 2022
04:05pm, Tuesday, 12'th Jul 2022
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera to Report Second Quarter 2022 Financial Results on August 9, 2022
AbCellera Biologics Inc. (ABCL) Stock Jumps 9.3%: Will It Continue to Soar?
10:06am, Monday, 20'th Jun 2022
AbCellera Biologics Inc. (ABCL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in t
AbCellera Biologics: Fully Funded, With New Opportunities And Massive Insider Buying
07:24am, Monday, 06'th Jun 2022
AbCellera stock has continued to struggle of late given the absolutely terrible sentiment in the biotech market, however the company's actual business is thriving under the surface. In the Q1 earnings
Why AbCellera Biologics Is 10% Lower Today
12:54pm, Wednesday, 11'th May 2022
The company has a plan for life after COVID-19, though it pales in comparison.
AbCellera Biologics Inc. (ABCL) CEO Dr. Carl Hansen on Q1 2022 Results - Earnings Call Transcript
09:55pm, Tuesday, 10'th May 2022
AbCellera Biologics Inc. (NASDAQ:ABCL ) Q1 2022 Results Conference Call May 10, 2022 5:00 PM ET Company Participants Tryn Stimart - Chief Legal and Compliance Officer Dr. Carl Hansen - President and C
AbCellera Biologics Inc. (ABCL) Beats Q1 Earnings and Revenue Estimates
06:49pm, Tuesday, 10'th May 2022
AbCellera Biologics Inc. (ABCL) delivered earnings and revenue surprises of 14.89% and 22.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stoc
3 Biotech Stocks Under $10 to Add to Your Buy List
07:17am, Tuesday, 26'th Apr 2022
These biotech stocks to buy are all profitable, which is important for investors looking to reduce their investment risk. The post 3 Biotech Stocks Under $10 to Add to Your Buy List appeared first on
AbCellera Biologics: Potentially Bottoming Out Amidst Terrible Market Sentiment
01:50am, Friday, 22'nd Apr 2022
AbCellera, the stock, has had a woeful two plus years as a public company; however, AbCellera the business is performing brilliantly. The company recently announced an internally developed T-Cell enga
AbCellera to Report First Quarter 2022 Financial Results on May 10, 2022
04:05pm, Tuesday, 12'th Apr 2022
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera to Report First Quarter 2022 Financial Results on May 10, 2022
